Reliance Chemotex Industries Limited has informed the Exchange regarding Board meeting held on August 14, 2025.
RELCHEMQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Reliance Chemotex Industries' board approved unaudited Q1 FY26 (quarter ended June 30, 2025) results. Revenue from operations rose to Rs. 9,236.37 lakh from Rs. 8,220.26 lakh in Q1 FY25, a growth of about 12%. However, net profit fell sharply to Rs. 106.33 lakh from Rs. 184.02 lakh, down nearly 42% year-on-year, as other income dropped and finance costs rose. The board also approved the re-appointment of Cost Auditor M/s. N. N. & Associates for FY 2025-26 and Secretarial Auditor M/s. Bhandari & Associates for a five-year term. The 47th AGM is set for September 26, 2025, with a record date of September 19, 2025 for the purpose of dividend payment.
Mixed signals for shareholders: revenue growth is steady but profitability is under pressure with a sharp drop in net profit and squeezed margins. The declared record date for dividend and AGM scheduling are routine but confirm a dividend payout for FY25.